基因ID | taxid | GeneDate LocusTag | Symbol Synonyms | Symbolfna Fullnamefna | dbXrefs | chromosome maplocation | description | genetype fnastatus | Otherdesignations | Featuretype |
109437 | 10090 | 20170408 | Etlm1 | Etlm1 ethanol induced locomotion 1 | MGI:MGI:2137481 | 1 | ethanol induced locomotion 1 | unknown O | ||
109438 | 10090 | 20170408 | Etlm2 | Etlm2 ethanol induced locomotion 2 | MGI:MGI:2137482 | 2 | ethanol induced locomotion 2 | unknown O | ||
109439 | 10090 | 20170408 | Etlm3 | Etlm3 ethanol induced locomotion 3 | MGI:MGI:2137483 | 6 | ethanol induced locomotion 3 | unknown O | ||
109443 | 10090 | 20170408 | Rapop1 | Rapop1 radiation-induced apoptosis 1 | MGI:MGI:103275 | 16 16 22.4 cM | radiation-induced apoptosis 1 | unknown O | ||
109445 | 10090 | 20211016 | Pbd2 Cti1 | Pbd2 peak bone density 2 | MGI:MGI:1345613 | 13 13 12.94 cM | peak bone density 2 | unknown O | ||
109447 | 10090 | 20220424 | Par2 | Par2 pulmonary adenoma resistance 2 | MGI:MGI:1855887 | 18 18 44.19 cM | pulmonary adenoma resistance 2 | unknown O | ||
109448 | 10090 | 20170408 | Pas1b Sluc3 | Pas1b pulmonary adenoma susceptibility 1b | MGI:MGI:109208 | 6 | pulmonary adenoma susceptibility 1b | unknown O | ||
109449 | 10090 | 20170408 | Bhr5 | Bhr5 bronchial hyperresponsiveness 5 | MGI:MGI:1351272 | 6 6 53.29 cM | bronchial hyperresponsiveness 5 | unknown O | ||
109450 | 10090 | 20170408 | Hpic1 | Hpic1 haloperidol-induced catalepsy 1 | MGI:MGI:2137472 | 9 9 46.58 cM | haloperidol-induced catalepsy 1 | unknown O | ||
109451 | 10090 | 20170408 | Hpic2 | Hpic2 haloperidol induced catalepsy 2 | MGI:MGI:2137474 | 1 1 81.08 cM | haloperidol induced catalepsy 2 | unknown O | ||
109452 | 10090 | 20170408 | Cia6 | Cia6 collagen induced arthritis QTL 6 | MGI:MGI:1345671 | 6 6 32.53 cM | collagen induced arthritis QTL 6 | unknown O | ||
109453 | 10090 | 20170408 | Hpic3 | Hpic3 haloperidol induced catalepsy 3 | MGI:MGI:2137476 | 14 | haloperidol induced catalepsy 3 | unknown O | ||
109454 | 10090 | 20170408 | Hpic4 | Hpic4 haloperidol induced catalepsy 4 | MGI:MGI:2137477 | 14 | haloperidol induced catalepsy 4 | unknown O | ||
109455 | 10090 | 20211016 | Cia1 mCia1 | Cia1 collagen induced arthritis QTL 1 | MGI:MGI:1345674 | 17 | collagen induced arthritis QTL 1 | unknown O | ||
109456 | 10090 | 20170408 | Exq3 | Exq3 exploratory and excitability QTL 3 | MGI:MGI:1314869 | 1 | exploratory and excitability QTL 3 | unknown O | ||
109457 | 10090 | 20170408 | Pas9 | Pas9 pulmonary adenoma susceptibility 9 | MGI:MGI:1345292 | 4 | pulmonary adenoma susceptibility 9 | unknown O | ||
109458 | 10090 | 20211016 | Estq2 Est2 | Estq2 estradiol regulated response QTL 2 | MGI:MGI:1346095 | 5 5 17.33 cM | estradiol regulated response QTL 2 | unknown O | ||
109459 | 10090 | 20211016 | Estq1 Est1 | Estq1 estradiol regulated response QTL 1 | MGI:MGI:1346097 | 4 4 22.38 cM | estradiol regulated response QTL 1 | unknown O | ||
109460 | 10090 | 20170408 | Pas1c | Pas1c pulmonary adenoma susceptibility 1c | MGI:MGI:1345294 | 6 6 39.71 cM | pulmonary adenoma susceptibility 1c | unknown O | ||
109461 | 10090 | 20170408 | Tlsr4 | Tlsr4 thymic lymphoma suppressor region 4 | MGI:MGI:1345498 | 4 4 39.46 cM | thymic lymphoma suppressor region 4 | unknown O | ||
109462 | 10090 | 20170408 | Tlsr5 | Tlsr5 thymic lymphoma suppressor region 5 | MGI:MGI:1345499 | 4 | thymic lymphoma suppressor region 5 | unknown O | ||
109463 | 10090 | 20170408 | Pas10 | Pas10 pulmonary adenoma susceptibility 10 | MGI:MGI:1345293 | 13 13 31.02 cM | pulmonary adenoma susceptibility 10 | unknown O | ||
109464 | 10090 | 20170408 | Pas5b | Pas5b pulmonary adenoma susceptibility 5b | MGI:MGI:1345295 | 11 11 59.82 cM | pulmonary adenoma susceptibility 5b | unknown O | ||
109465 | 10090 | 20211016 | Cms1 Cms | Cms1 resistance to Coccidioides immitis 1 | MGI:MGI:1346025 | 4 | resistance to Coccidioides immitis 1 | unknown O | ||
109466 | 10090 | 20170408 | Cms2 | Cms2 resistance to Coccidioides immitis 2 | MGI:MGI:1346026 | 6 | resistance to Coccidioides immitis 2 | unknown O | ||
109467 | 10090 | 20211016 | Pas2 Pas-2 | Pas2 pulmonary adenoma susceptibility 2 | MGI:MGI:97482 | 17 17 17.98 cM | pulmonary adenoma susceptibility 2 | unknown O | ||
109468 | 10090 | 20170408 | Itbq1 | Itbq1 inspiratory timing at baseline QTL 1 | MGI:MGI:1328329 | 3 3 22.62 cM | inspiratory timing at baseline QTL 1 | unknown O | ||
109469 | 10090 | 20211016 | Hcs3 Hcs | Hcs3 hepatocarcinogenesis susceptibility 3 | MGI:MGI:96058 | 12 | hepatocarcinogenesis susceptibility 3 | unknown O | ||
109470 | 10090 | 20211016 | Crhq1 Crh1 | Crhq1 compensatory renal hypertrophy QTL 1 | MGI:MGI:1298385 | 11 11 62.4 cM | compensatory renal hypertrophy QTL 1 | unknown O | ||
109471 | 10090 | 20170408 | Lore1 | Lore1 loss of righting induced by ethanol 1 | MGI:MGI:1096557 | 1 1 44.69 cM | loss of righting induced by ethanol 1 | unknown O | ||
109472 | 10090 | 20170408 | Lore7 | Lore7 loss of righting induced by ethanol 7 | MGI:MGI:1096563 | 7 | loss of righting induced by ethanol 7 | unknown O | ||
109473 | 10090 | 20170408 | Lore6 | Lore6 loss of righting induced by ethanol 6 | MGI:MGI:1096564 | 18 | loss of righting induced by ethanol 6 | unknown O | ||
109476 | 10090 | 20170408 | Hcbip2 | Hcbip2 hexachlorobenzene induced porphyria 2 | MGI:MGI:1345640 | 17 | hexachlorobenzene induced porphyria 2 | unknown O | ||
109477 | 10090 | 20170408 | Hcbip1 | Hcbip1 hexachlorobenzene induced porphyria 1 | MGI:MGI:1345654 | 14 | hexachlorobenzene induced porphyria 1 | unknown O | ||
109478 | 10090 | 20170408 | Mlviq2 | Mlviq2 murine leukemia virus infection QTL, 2 | MGI:MGI:1306808 | 19 | murine leukemia virus infection QTL, 2 | unknown O | ||
109479 | 10090 | 20170408 | Yaa1 | Yaa1 Y-linked autoimmune acceleration QTL 1 | MGI:MGI:1345663 | 13 13 30.06 cM | Y-linked autoimmune acceleration QTL 1 | unknown O | ||
109480 | 10090 | 20170408 | Aem2 | Aem2 anti-erythrocyte autoantibody modifier 2 | MGI:MGI:2137852 | 7 7 45.71 cM | anti-erythrocyte autoantibody modifier 2 | unknown O | ||
109481 | 10090 | 20170408 | Sles4 | Sles4 systemic lupus erythmatosus suppressor 4 | MGI:MGI:1353456 | 9 9 2.46 cM | systemic lupus erythmatosus suppressor 4 | unknown O | ||
109482 | 10090 | 20170408 | Sles2 | Sles2 systemic lupus erythmatosus suppressor 2 | MGI:MGI:1353462 | 4 4 57.76 cM | systemic lupus erythmatosus suppressor 2 | unknown O | ||
109483 | 10090 | 20170408 | Sles3 | Sles3 systemic lupus erythmatosus suppressor 3 | MGI:MGI:1353463 | 3 3 34.91 cM | systemic lupus erythmatosus suppressor 3 | unknown O | ||
109484 | 10090 | 20170408 | Aem3 | Aem3 anti-erythrocyte autoantibody modifier 3 | MGI:MGI:2137853 | 10 10 39.72 cM | anti-erythrocyte autoantibody modifier 3 | unknown O | ||
109485 | 10090 | 20170408 | Cplaq1 | Cplaq1 circadian period of locomotor activity 1 | MGI:MGI:1277094 | 3 | circadian period of locomotor activity 1 | unknown O | ||
109486 | 10090 | 20170408 | Cplaq4 | Cplaq4 circadian period of locomotor activity 4 | MGI:MGI:1277130 | 1 1 10.96 cM | circadian period of locomotor activity 4 | unknown O | ||
109487 | 10090 | 20170408 | Cplaq3 | Cplaq3 circadian period of locomotor activity 3 | MGI:MGI:1277142 | 1 | circadian period of locomotor activity 3 | unknown O | ||
109488 | 10090 | 20170408 | Cplaq5 | Cplaq5 circadian period of locomotor activity 5 | MGI:MGI:1277144 | 5 | circadian period of locomotor activity 5 | unknown O | ||
109489 | 10090 | 20170408 | Cplaq7 | Cplaq7 circadian period of locomotor activity 7 | MGI:MGI:1277146 | 2 2 62.89 cM | circadian period of locomotor activity 7 | unknown O | ||
109490 | 10090 | 20170408 | Cplaq6 | Cplaq6 circadian period of locomotor activity 6 | MGI:MGI:1277147 | 5 | circadian period of locomotor activity 6 | unknown O | ||
109491 | 10090 | 20170408 | Sles1 | Sles1 systemic lupus erythmatosus suppressor 1 | MGI:MGI:1353464 | 17 17 18.31 cM | systemic lupus erythmatosus suppressor 1 | unknown O | ||
109492 | 10090 | 20170408 | Nidd1 | Nidd1 non-insulin-dependent diabetes mellitus 1 | MGI:MGI:1277966 | 4 | non-insulin-dependent diabetes mellitus 1 | unknown O | ||
109493 | 10090 | 20170408 | Alcp5 | Alcp5 alcohol preference locus 5, male specific | MGI:MGI:1858454 | 2 2 103.43 cM | alcohol preference locus 5, male specific | unknown O |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |